These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15599391)

  • 1. Platelets and metastasis revisited: a novel fatty link.
    Gupta GP; Massagué J
    J Clin Invest; 2004 Dec; 114(12):1691-3. PubMed ID: 15599391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.
    Boucharaba A; Serre CM; Grès S; Saulnier-Blache JS; Bordet JC; Guglielmi J; Clézardin P; Peyruchaud O
    J Clin Invest; 2004 Dec; 114(12):1714-25. PubMed ID: 15599396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelets are associated with xenograft tumor growth and the clinical malignancy of ovarian cancer through an angiogenesis-dependent mechanism.
    Yuan L; Liu X
    Mol Med Rep; 2015 Apr; 11(4):2449-58. PubMed ID: 25502723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice.
    Lev DC; Kim SJ; Onn A; Stone V; Nam DH; Yazici S; Fidler IJ; Price JE
    Clin Cancer Res; 2005 Jan; 11(1):306-14. PubMed ID: 15671560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin inhibits platelets from reprogramming breast tumor cells and promoting metastasis.
    Johnson KE; Ceglowski JR; Roweth HG; Forward JA; Tippy MD; El-Husayni S; Kulenthirarajan R; Malloy MW; Machlus KR; Chen WY; Italiano JE; Battinelli EM
    Blood Adv; 2019 Jan; 3(2):198-211. PubMed ID: 30670536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HRG regulates tumor progression, epithelial to mesenchymal transition and metastasis via platelet-induced signaling in the pre-tumorigenic microenvironment.
    Cedervall J; Zhang Y; Ringvall M; Thulin A; Moustakas A; Jahnen-Dechent W; Siegbahn A; Olsson AK
    Angiogenesis; 2013 Oct; 16(4):889-902. PubMed ID: 23793459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin and P2Y12 inhibition attenuate platelet-induced ovarian cancer cell invasion.
    Cooke NM; Spillane CD; Sheils O; O'Leary J; Kenny D
    BMC Cancer; 2015 Sep; 15():627. PubMed ID: 26353776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of Integrins in Cancer Cells and Anti-Platelet Properties Are Involved in Holothurian Glycosaminoglycan-Mediated Disruption of the Interaction of Cancer Cells and Platelets in Hematogenous Metastasis.
    Qian W; Tao L; Wang Y; Zhang F; Li M; Huang S; Wang A; Chen W; Yue Z; Chen L; Liu Y; Huang C; Zhang L; Li Y; Lu Y
    J Vasc Res; 2015; 52(3):197-209. PubMed ID: 26488158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Platelet Lifeline to Cancer: Challenges and Opportunities.
    Haemmerle M; Stone RL; Menter DG; Afshar-Kharghan V; Sood AK
    Cancer Cell; 2018 Jun; 33(6):965-983. PubMed ID: 29657130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2.
    Eder AM; Sasagawa T; Mao M; Aoki J; Mills GB
    Clin Cancer Res; 2000 Jun; 6(6):2482-91. PubMed ID: 10873103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases.
    Boucharaba A; Serre CM; Guglielmi J; Bordet JC; Clézardin P; Peyruchaud O
    Proc Natl Acad Sci U S A; 2006 Jun; 103(25):9643-8. PubMed ID: 16769891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo.
    Kim KS; Sengupta S; Berk M; Kwak YG; Escobar PF; Belinson J; Mok SC; Xu Y
    Cancer Res; 2006 Aug; 66(16):7983-90. PubMed ID: 16912173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lysophosphatidic acid: a new link between blood platelets and bone metastasis].
    Peyruchaud O; Boucharaba A; Saulnier-Blache JS; Clézardin P
    Med Sci (Paris); 2005 Apr; 21(4):353-5. PubMed ID: 15811296
    [No Abstract]   [Full Text] [Related]  

  • 14. Drawing a link between the thromboxane A
    Serhan K; Gartung A; Panigrahy D
    Prostaglandins Other Lipid Mediat; 2018 Jul; 137():40-45. PubMed ID: 29933028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet function: does it offer a chance of better cancer progression control?
    Sierko E; Wojtukiewicz MZ
    Semin Thromb Hemost; 2007 Oct; 33(7):712-21. PubMed ID: 18000800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet glycoprotein VI as a mediator of metastasis.
    Farndale RW
    J Thromb Haemost; 2009 Oct; 7(10):1711-2. PubMed ID: 19682240
    [No Abstract]   [Full Text] [Related]  

  • 17. Human Cancer and Platelet Interaction, a Potential Therapeutic Target.
    Wang S; Li Z; Xu R
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29677116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin activation controls metastasis in human breast cancer.
    Felding-Habermann B; O'Toole TE; Smith JW; Fransvea E; Ruggeri ZM; Ginsberg MH; Hughes PE; Pampori N; Shattil SJ; Saven A; Mueller BM
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1853-8. PubMed ID: 11172040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelets and cancer: implications for antiangiogenic therapy.
    Trikha M; Nakada MT
    Semin Thromb Hemost; 2002 Feb; 28(1):39-44. PubMed ID: 11885024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of hypoxia-inducible factor-1alpha is necessary for lysophosphatidic acid-induced vascular endothelial growth factor expression.
    Lee J; Park SY; Lee EK; Park CG; Chung HC; Rha SY; Kim YK; Bae GU; Kim BK; Han JW; Lee HY
    Clin Cancer Res; 2006 Nov; 12(21):6351-8. PubMed ID: 17085645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.